We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
n-3 fatty acids and rosiglitazone improve insulin sensitivity through additive stimulatory effects on muscle glycogen synthesis in mice fed a high-fat diet.
- Authors
Kuda, O; Jelenik, T; Jilkova, Z; Flachs, P; Rossmeisl, M; Hensler, M; Kazdova, L; Ogston, N; Baranowski, M; Gorski, J; Janovska, P; Kus, V; Polak, J; Mohamed-Ali, V; Burcelin, R; Cinti, S; Bryhn, M; Kopecky, J
- Abstract
Fatty acids of marine origin, i.e. docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) act as hypolipidaemics, but they do not improve glycaemic control in obese and diabetic patients. Thiazolidinediones like rosiglitazone are specific activators of peroxisome proliferator-activated receptor gamma, which improve whole-body insulin sensitivity. We hypothesised that a combined treatment with a DHA and EPA concentrate (DHA/EPA) and rosiglitazone would correct, by complementary additive mechanisms, impairments of lipid and glucose homeostasis in obesity.
- Publication
Diabetologia, 2009, Vol 52, Issue 5, p941
- ISSN
1432-0428
- Publication type
Journal Article
- DOI
10.1007/s00125-009-1305-z